Gamma-Glutamyltransferase Levels in Ascitic Fluid and Liver From Patients With Primary Hepatoma.

BMJ

doi 10.1136/bmj.1.6076.1576

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ

Related search

Do Gamma‐glutamyltransferase Levels Identify HCV Patients Who Require Lifelong Post‐SVR Follow‐up?

Liver International
Hepatology
2020English

Serum Gamma-Glutamyltransferase and the Burden of Atherosclerosis in Patients With Acute Coronary Syndrome

Turk Kardiyoloji Dernegi Arsivi
Cardiovascular MedicineCardiology
2013English

Prognostic Value of Serum Gamma-Glutamyltransferase, Calcium, and Inorganic Phosphorus Levels in Short-Term Mortality of Patients With Acute Coronary Syndrome

Istanbul Medical Journal
2015English

Pruritus in Patients With Chronic Liver Disease and Serum Autotaxin Levels in Patients With Primary Biliary Cholangitis

BMC Gastroenterology
MedicineGastroenterology
2019English

Extracorporal Modified Ascitic Fluid Reinfusion in Treatment of Resistant Ascites in Liver Cirrhosis

Grekov's Bulletin of Surgery
2017English

Serum Gamma-Glutamyltransferase Levels Are Associated With Cardiovascular Risk Factors in China: A Nationwide Population-Based Study

Scientific Reports
Multidisciplinary
2018English

Dissimilar Tumor Cell Populations in Ascitic Fluid of Ovarian Cancer Patients

Bulletin of Siberian Medicine
Molecular Medicine
2020English

The Contribution of Ascitic Fluid to Body Weight in Patients With Liver Cirrhosis, and Its Estimation Using Girth: A Cross‐sectional Observational Study

Journal of Human Nutrition and Dietetics
MedicineNutritionDietetics
2019English

Pretherapeutic Gamma-Glutamyltransferase Is an Independent Prognostic Factor for Patients With Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy